Trials / Recruiting
RecruitingNCT05022420
SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Biopsies are performed in several autoimmune diseases to diagnose or classify them Tolerance and information of the patients have been poorly evlauated our objective is to evaluate tolerance and information of the patients after the biopsies for salivary gland, temporal arteries and neuromuscular.
Detailed description
patinets that benefited of arterial temporal biospy or salivary gland biospy or muscuar biopsy or neuro muscular biospy for his auto -mmune disease will be included and fill standardized questionnaires concerning tolerance, information and side effect at inclusion , day 7 and day 30 after the biopsy data will be analysed to evaluate information, tolerance and risk factor af side effect
Conditions
Timeline
- Start date
- 2021-08-19
- Primary completion
- 2025-02-18
- Completion
- 2025-02-18
- First posted
- 2021-08-26
- Last updated
- 2024-04-05
Locations
8 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05022420. Inclusion in this directory is not an endorsement.